Thyroid Hormone Receptor beta Agonist [EPC] - N0000194131

Pharmacologic Class Information

Pharmacologic Code N0000194131
Pharmacologic Name Thyroid Hormone Receptor beta Agonist
Pharmacologic Uses
  • thyroid hormone receptor-beta (THR-beta) agonist
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Thyroid Hormone Receptor beta Agonist

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Thyroid Hormone Receptor beta Agonist [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
82576-060Rezdiffra Non-Proprietary Name: ResmetiromTablet, CoatedOralMadrigal Pharmaceuticals, Inc.ACTIVE
82576-080Rezdiffra Non-Proprietary Name: ResmetiromTablet, CoatedOralMadrigal Pharmaceuticals, Inc.ACTIVE
82576-100Rezdiffra Non-Proprietary Name: ResmetiromTablet, CoatedOralMadrigal Pharmaceuticals, Inc.ACTIVE